Positron emission tomography experience with 2‐[18F]fluoro‐3‐(2(s)‐azetidinylmethoxy)pyridine (2‐[18F]fa) in the living human brain of smokers with paranoid schizophrenia
暂无分享,去创建一个
Yun Zhou | John Hilton | Vanessa Raymont | James Robert Brašić | Nicola Cascella | Andrew Crabb | Dean Foster Wong | D. Wong | A. Horti | J. Hilton | Yun Zhou | Anil Kumar | V. Raymont | N. Cascella | Andrew G Horti | Maria Guevara | Anil Kumar | Maria Rita Guevara | A. Crabb
[1] Marianne Patt,et al. Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380). , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[2] James Robert Brašić. Documentation of demographic data. , 2003, Psychological Reports.
[3] Yun Zhou,et al. Single photon emission computed tomography experience with (S)‐5‐[123I]iodo‐3‐(2‐azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers , 2009, Synapse.
[4] S. Dursun,et al. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study , 1997, Psychological Medicine.
[5] J. Seibyl,et al. Quantification of Smoking-Induced Occupancy of β2-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding , 2010, The Journal of Nuclear Medicine.
[6] H. Shimizu,et al. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. , 1999, Addictive behaviors.
[7] James Robert Brašić,et al. Behavioral Effects of Clomipramine on Prepubertal Boys With Autistic Disorder and Severe Mental Retardation , 1998, CNS Spectrums.
[8] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[9] G. Simpson,et al. A rating scale for tardive dyskinesia , 1979, Psychopharmacology.
[10] J. Thompson. Behavioural Psychotherapy: Maudsley Pocket Book of Clinical Management. , 1992 .
[11] Yun Zhou,et al. A New Linear Parametric Imaging Algorithm Derived from a Simplified Reference Tissue Model for Ligand-Receptor Dynamic PET Studies , 2002 .
[12] Svetlana I. Chefer,et al. Cigarette Smoking Saturates Brain α4β2 Nicotinic Acetylcholine Receptors , 2006 .
[13] J. Gault,et al. Smoking and schizophrenia: abnormal nicotinic receptor expression. , 2000, European journal of pharmacology.
[14] H. Kuwabara,et al. Neural Activation During Performance of Number-Letter Sequencing , 2000, Applied neuropsychology.
[15] Suck-Won Kim,et al. The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.
[16] Mark T. Madsen,et al. Single Photon Emission Computed Tomography (SPECT) , 2002 .
[17] D. Cohen,et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.
[18] Dc Washington. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .
[19] M. Kassiou,et al. Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning , 2007, Neuroscience Letters.
[20] Karl J. Friston,et al. Incorporating Prior Knowledge into Image Registration , 1997, NeuroImage.
[21] Monique Ernst,et al. 2 [18F]F‐A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] P. Wender,et al. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. , 1993, The American journal of psychiatry.
[23] A. C. Collins,et al. Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia , 2000, Neuropsychopharmacology.
[24] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] A. Mukhin,et al. A simplified method for the measurement of nonmetabolized 2-[18F]F-A-85380 in blood plasma using solid-phase extraction. , 2007, Nuclear medicine and biology.
[26] M. Woerner,et al. Anchoring the BPRS: an aid to improved reliability. , 1988, Psychopharmacology bulletin.
[27] M. Thase,et al. Psychiatric rating scales. , 2012, Handbook of clinical neurology.
[28] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[29] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[30] Sung-Cheng Huang,et al. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model , 2003, NeuroImage.
[31] P. Sachdev. A rating scale for acute drug-induced akathisia: development, reliability, and validity , 1994, Biological Psychiatry.
[32] T. Rustin. Assessing nicotine dependence. , 2000, American family physician.
[33] D. Wong,et al. Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.
[34] M. Denckla,et al. Revised Neurological Examination for Subtle Signs (1985). , 1985, Psychopharmacology bulletin.
[35] F. Jessen,et al. Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain , 2008, Neuroscience Letters.
[36] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[37] Swen Hesse,et al. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[38] A. Rahmim,et al. The second generation HRRT - a multi-centre scanner performance investigation , 2005, IEEE Nuclear Science Symposium Conference Record, 2005.
[39] John L. Musachio,et al. Human [/sup 123/I]5-I-A-85380 dynamic SPECT studies in normals: kinetic analysis and parametric imaging , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).
[40] J. Overall,et al. The Brief Psychiatric Rating Scale , 1962 .
[41] P. Sanberg,et al. Nicotine for the treatment of Tourette's syndrome. , 1997, Pharmacology & therapeutics.
[42] M. Goldstein,et al. Neuropsychiatric assessment. , 2005, The Psychiatric clinics of North America.
[43] M. Mandelkern,et al. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. , 2005, Nuclear medicine and biology.
[44] D. Wong,et al. Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors. , 2009, PET clinics.
[45] J. Links,et al. In Vivo Measurement of Dopamine Receptors in Human Brain by Positron Emission Tomography Age and Sex Differences a , 1988, Annals of the New York Academy of Sciences.
[46] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.
[47] Sowmyanarayanan Sadagopan,et al. WWW: service provider , 2002, UBIQ.
[48] James Robert Brašić. Documentation of Ethnicity , 2004, Psychological reports.
[49] Hiroto Kuwabara,et al. Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. , 2010, Life sciences.
[50] James Robert Brašić,et al. Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance. , 2000, Medical hypotheses.
[51] R. Conley,et al. Novel Factor-Based Symptom Scores in Treatment Resistant Schizophrenia: Implications for Clinical Trials , 2002, Neuropsychopharmacology.
[52] H. Vankova. Mini Mental State , 2010 .
[53] Abnormal Involuntary Movement Scale (AIMS). , 1988, Psychopharmacology bulletin.
[54] K. Fagerström,et al. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. , 1996, Pharmacology & therapeutics.
[55] D. V. Jeste,et al. Tardive dyskinesia. , 1993, Schizophrenia bulletin.
[56] P. Gillig,et al. Attention-Deficit/Hyperactivity Disorder in Adults , 2004 .
[57] James Robert Brašić,et al. In vivo imaging of neurotransmitter systems in neuropsychiatry , 2001, Clinical Neuroscience Research.
[58] P. Wender. Attention-deficit hyperactivity disorder in adults. , 1995, The Psychiatric clinics of North America.
[59] T. Barnes. A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.
[60] Johannes Schwarz,et al. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. , 2009, Archives of general psychiatry.
[61] J. Ashburner,et al. Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.
[62] P. Brust,et al. Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. , 2007, Nuclear medicine and biology.
[63] Dean F. Wong,et al. Positron emission tomography--a tool for identifying the effects of alcohol dependence on the brain. , 2003 .
[64] James Robert Brašić,et al. Brain imaging research: Does the science serve clinical practice? , 2007, International review of psychiatry.
[65] Henry A. Nasrallah,et al. Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology , 2008, Schizophrenia Research.
[66] James Robert Brašić. Treatment of movement disorders in autism spectrum disorders , 2003 .
[67] H. Kuwabara,et al. Age-Related Changes in Neural Activation During Working Memory Performance , 2000 .